NMO-IgG in the diagnosis of neuromyelitis optica
- 27 March 2007
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (13), 1076-1077
- https://doi.org/10.1212/01.wnl.0000256822.01222.bd
Abstract
We studied 36 unselected patients with NMO (33 relapsing, three monophasic). All patients met the 1999 criteria of Wingerchuk et al.3 Spinal cord lesions in three or more segments were present in 35 of 36. Median follow-up from onset was 38 months. In addition, we tested 80 patients with MS according to the revised McDonald criteria4 (71% relapsing-remitting, 20% secondary progressive, 9% primary progressive), five patients with longitudinally extensive transverse myelitis (LETM),1,5 11 patients with non-LETM myelitis, 21 with miscellaneous neurologic disorders, and 25 healthy controls.This publication has 6 references indexed in Scilit:
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelThe Journal of Experimental Medicine, 2005
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- The clinical course of neuromyelitis optica (Devic’s syndrome)Neurology, 1999